Volume | 120,621 |
|
|||||
News | (2) | ||||||
Day High | 3.00 | Low High |
|||||
Day Low | 2.71 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
NovaBay Pharmaceuticals Inc New | NBY | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3.00 | 2.71 | 3.00 | 2.71 | 2.98 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
1,885 | 120,621 | US$ 2.83 | US$ 341,208 | - | 0.065 - 3.55 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
19:00:00 | 796 | US$ 2.71 | USD |
NovaBay Pharmaceuticals Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.09M | 6.53M | - | 14.73M | -16.7M | -2.56 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NovaBay Pharmaceuticals News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBY Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.35 | 3.55 | 2.70 | 3.13 | 185,467 | -0.56 | -16.72% |
1 Month | 0.0866 | 3.55 | 0.075 | 0.1486647 | 24,733,566 | 2.70 | 3,121.71% |
3 Months | 0.134 | 3.55 | 0.065 | 0.1398419 | 9,821,580 | 2.66 | 1,982.09% |
6 Months | 0.30 | 3.55 | 0.065 | 0.146921 | 6,140,627 | 2.49 | 830.00% |
1 Year | 0.62 | 3.55 | 0.065 | 0.1977772 | 3,394,054 | 2.17 | 350.00% |
3 Years | 25.1965 | 30.702 | 0.065 | 4.73 | 1,705,424 | -22.41 | -88.93% |
5 Years | 11.55 | 167.30 | 0.065 | 24.49 | 2,125,959 | -8.76 | -75.84% |
NovaBay Pharmaceuticals Description
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. |